IFNG and neoplasm: Cpt-DNA adducts within tumour tissues were increased by anti-IFNγ treatment and the effective rate of drug delivery was increased by about 113% (cisplatin: 2.55%; cisplatin combined with anti-IFNγ: 5.44%) (Figure 5E), as shown by immunostaining.